A method of treatment of the symptoms of tinnitus is disclosed in which a non-sinusoidal pulsating electric waveform having a pulse repetition rate (frequency) less than 100 Hz is applied to a headphone or an earphone or a like acoustic transducer worn by a tinnitus sufferer. Square, sawtooth and triangular waveforms are suitable. Preferably a sequence of square, triangular, square and square waveforms each of duration of 3 minutes, and separated by a silent pause of 10-15 seconds, is applied. Various devices for applying such waveform(s) to such transducers are disclosed including a clinical oscillator, an internet distribution system, a playback device, electronic or magnetic storage devices, and a cochlear implant.

A tinnitus treatment system comprising a sound processing unit, a haptic stimulus unit and an audio delivery unit. The sound processing unit comprises a processor input for receiving an audio signal; and a digital signal processor operable to analyse said audio signal and generate a plurality of actuation signals therefrom which are representative of said audio signal. The digital signal processor is further operable to spectrally modify said audio signal in accordance with a predetermined modification profile to generate a modified audio signal. The haptic stimulus unit comprises an array of stimulators each of which can be independently actuated to apply a tactile stimulus to a subject; and a stimulus unit input for receiving the plurality of actuation signals generated by said digital signal processor and directing individual actuation signals to individual stimulators. The audio delivery unit comprises an audio delivery unit input for receiving the modified audio signal generated by said digital signal processor.

A tinnitus treatment device includes a database module storing a Shepard scale that includes multiple Shepard tones, and a playback control module configured to repeatedly execute a loop playback procedure. In the loop playback procedure, the playback control module reads the Shepard scale from the database module, and outputs the Shepard scale multiple times to an audio output device in a manner that the Shepard tones are outputted in order from high frequency to low frequency. The playback control module stops output of the Shepard scale for a resting-time interval after each execution of the loop playback procedure, and a length of the resting-time interval is equal to time taken for a single execution of the loop playback procedure.

Exemplary light control devices and methods provide a regional variation of visual information and sampling (V-VIS) of an ocular field of view that improves or stabilizes vision, ameliorates a visual symptom, reduces the rate of vision loss, or reduces the progression of an ophthalmic or neurologic condition, disease, injury or disorder. The V-VIS devices and methods generate a moving aperture effect anterior to a retina that samples and delivers to the retina environmental light from an ocular field of view at a sampling rate between 50 hertz and 50 kilohertz. Certain of these V-VIS devices and methods may be combined with augmented or virtual reality, vision measurement, vision monitoring, or other therapies including, but not limited to, pharmacological, gene, retinal replacement and stem cell therapies.

Exemplary light control devices and methods provide a regional variation of visual information and sampling (V-VIS) of an ocular field of view that improves or stabilizes vision, ameliorates a visual symptom, reduces the rate of vision loss, or reduces the progression of an ophthalmic or neurologic condition, disease, injury or disorder. The V-VIS devices and methods generate a moving aperture effect anterior to a retina that samples and delivers to the retina environmental light from an ocular field of view at a sampling rate between 50 hertz and 50 kilohertz. Certain of these V-VIS devices and methods may be combined with augmented or virtual reality, vision measurement, vision monitoring, or other therapies including, but not limited to, pharmacological, gene, retinal replacement and stem cell therapies.

A tinnitus treatment device using a surround sound virtual reality (VR) interface of the present invention includes a display unit that is mounted on a user's head to display a VR video, into which a tinnitus avatar is inserted, to a subject, a virtual environment object unit that generates the tinnitus avatar by visualizing the tinnitus perceived by the user, a surround sound processing unit that generates a 3D sound so as to allow the user to perceive a mixed sound combined with the tinnitus, a sound output unit that outputs the 3D sound to the user, and a VR video control unit that changes content in the VR video in response to a user input signal provided from a user interface, in which the VR video control unit controls the tinnitus avatar displayed in the VR video in response to the user input signal and changes the output of the 3D sound in response to the control of the tinnitus avatar.

A tinnitus treatment device using a surround sound virtual reality (VR) interface of the present invention includes a display unit that is mounted on a user's head to display a VR video, into which a tinnitus avatar is inserted, to a subject, a virtual environment object unit that generates the tinnitus avatar by visualizing the tinnitus perceived by the user, a surround sound processing unit that generates a 3D sound so as to allow the user to perceive a mixed sound combined with the tinnitus, a sound output unit that outputs the 3D sound to the user, and a VR video control unit that changes content in the VR video in response to a user input signal provided from a user interface, in which the VR video control unit controls the tinnitus avatar displayed in the VR video in response to the user input signal and changes the output of the 3D sound in response to the control of the tinnitus avatar.

Exemplary light control devices and methods provide a regional variation of visual information and sampling (V-VIS) of an ocular field of view that improves or stabilizes vision, ameliorates a visual symptom, reduces the rate of vision loss, or reduces the progression of an ophthalmic or neurologic condition, disease, injury or disorder. The V-VIS devices and methods generate a moving aperture effect anterior to a retina that samples and delivers to the retina environmental light from an ocular field of view at a sampling rate between 50 hertz and 50 kilohertz. Certain of these V-VIS devices and methods may be combined with augmented or virtual reality, vision measurement, vision monitoring, or other therapies including, but not limited to, pharmacological, gene, retinal replacement and stem cell therapies.

Exemplary light control devices and methods provide a regional variation of visual information and sampling (V-VIS) of an ocular field of view that improves or stabilizes vision, ameliorates a visual symptom, reduces the rate of vision loss, or reduces the progression of an ophthalmic or neurologic condition, disease, injury or disorder. The V-VIS devices and methods generate a moving aperture effect anterior to a retina that samples and delivers to the retina environmental light from an ocular field of view at a sampling rate between 50 hertz and 50 kilohertz. Certain of these V-VIS devices and methods may be combined with augmented or virtual reality, vision measurement, vision monitoring, or other therapies including, but not limited to, pharmacological, gene, retinal replacement and stem cell therapies.

This invention relates to a set of haptic gloves embedded with a taptic engine that connects to an iPhone via Bluetooth. The gloves are designed to vibrate in synchronization with the haptic music feature on iPhones, providing an enhanced sensory experience for users, particularly benefiting those who are deaf or hard of hearing. Additionally, the invention has potential applications in the medical field, specifically for rehabilitation purposes.